First Patient-Derived Stem Cell Transplant a Success in T1D

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

At 1 year, islets chemically reprogrammed from the patient’s own somatic cells allowed them to become insulin-independent with the use of immunosuppression.
Medscape Medical News